Skip to main content

Advertisement

SpringerLink
Log in

Endovascular Management of Refractory Hepatic Encephalopathy Complication of Transjugular Intrahepatic Portosystemic Shunt (TIPS): Comprehensive Review and Clinical Practice Algorithm

  • Review
  • Published:
CardioVascular and Interventional Radiology Aims and scope Submit manuscript

Abstract

Transjugular intrahepatic portosystemic shunt (TIPS) has evolved as an effective intervention for treatment of complications of portal hypertension. The use of polytetrafluoroethylene-covered stents have improved the patency of the shunts and diminished the incidence of TIPS dysfunction. However, TIPS-related refractory hepatic encephalopathy (rHE) poses a significant challenge. Approximately 3–7 % of patients with TIPS develop rHE. Refractory hepatic encephalopathy is defined as a recurrent or persistent encephalopathy despite appropriate medical treatment. Hepatic encephalopathy can be an extremely debilitating complication that profoundly affects quality of life. The approach to management of patients with rHE is complex and typically requires collaboration between different specialties. Liver transplantation is the ultimate treatment for rHE; however, the ongoing shortage of organ donation markedly limits this treatment option. Alternative therapies such as shunt occlusion or reduction can control symptoms and serve as a ‘bridge’ therapy to liver transplantation. Therefore, interventional radiologists play a key role in the management of these patients by offering a variety of endovascular techniques. The purpose of this review is to highlight some of these endovascular techniques and to develop a therapeutic algorithm that can be applied in clinical practice for the management of rHE.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Illustration A
Illustration B
Illustration C
Illustration D
Illustration E
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Fidelman N, Kwan SW, LaBerge JM, Gordon RL, Ring EJ, Kerlan RK Jr. The transjugular intrahepatic portosystemic shunt: an update. Am J Roentgenol. 2012;199(4):746–55.

    Article  Google Scholar 

  2. Felipo V. Hepatic encephalopathy: effects of liver failure on brain function. Nat Rev Neurosci. 2013;14(12):851–8.

    Article  CAS  PubMed  Google Scholar 

  3. Fanelli F, Salvatori FM, Rabuffi P, Boatta E, Riggio O, Lucatelli P, Passariello R. Management of refractory hepatic encephalopathy after insertion of TIPS: long-term results of shunt reduction with hourglass-shaped balloon-expandable stent-graft. Am J Roentgenol. 2009;193(6):1696–702.

    Article  Google Scholar 

  4. Poh Z, Chang PEJ. A Current review of the diagnostic and treatment strategies of hepatic encephalopathy. Int J Hepatol. 2012. doi:10.1155/2012/480309.

    PubMed Central  PubMed  Google Scholar 

  5. Vilstrup H, Amodio P, Bajaj J, Cordoba J, Ferenci P, Mullen KD, Weissenborn K, Wong P. Hepatic encephalopathy in chronic liver disease: 2014 practice guideline by the American association for the study of liver diseases and the European association for the study of the liver. Hepatology. 2014;60(2):715–35.

    Article  PubMed  Google Scholar 

  6. Riggio O, Nardelli S, Moscucci F, Pasquale C, Ridola L, Merli M. Hepatic encephalopathy after transjugular intrahepatic portosystemic shunt. Clin Liver Dis. 2012;16(1):133–46.

    Article  PubMed  Google Scholar 

  7. Sharma BC, Sharma P, Lunia MK, Srivastava S, Goyal R, Sarin SK. A randomized, double-blind, controlled trial comparing rifaximin plus lactulose with lactulose alone in treatment of overt hepatic encephalopathy. Am J Gastroenterol. 2013;108(9):1458–63.

    Article  CAS  PubMed  Google Scholar 

  8. Laleman W, Simon‐Talero M, Maleux G, Perez M, Ameloot K, Soriano G, Villalba J, Garcia‐Pagan JC, Garcia‐Pagan JC, Barrufet M, Jalan R. Embolization of large spontaneous portosystemic shunts for refractory hepatic encephalopathy: a multicenter survey on safety and efficacy. Hepatology. 2013;57(6):2448–57.

    Article  PubMed  Google Scholar 

  9. Bai M, He C, Yin Z, Niu J, Wang Z, Qi X, Liu L, Yang Z, Guo W, Tie J, Bai W, Xia J, Cai H, Wang J, Wu K, Fan D, Han G. Randomised clinical trial: l-ornithine-L-aspartate reduces significantly the increase of venous ammonia concentration after TIPSS. Aliment Pharmacol Ther. 2014;40(1):63–71.

    Article  CAS  PubMed  Google Scholar 

  10. Bass NM, Mullen KD, Sanyal A, Poordad F, Neff G, Leevy CB, Sigal S, Sheikh MY, Beavers K, Frederick T, Teperman L, Hillebrand D, Huang S, Merchant K, Shaw A, Bortey E, Forbes WP. Rifaximin treatment in hepatic encephalopathy. N Engl J Med. 2010;362(12):1071–81.

    Article  CAS  PubMed  Google Scholar 

  11. Wong RJ, Gish RG, Ahmed A. Hepatic encephalopathy is associated with significantly increased mortality among patients awaiting liver transplantation. Liver Transplant. 2014;20(12):1454–61.

    Google Scholar 

  12. Chung HH, Razavi MK, Sze DY, Frisoli JK, Kee ST, Dake MD, Hellinger JC, Kang BC. Portosystemic pressure gradient during transjugular intrahepatic portosystemic shunt with Viatorr stent graft: what is the critical low threshold to avoid medically uncontrolled low pressure gradient related complications? J Gastroenterol Hepatol. 2008;23(1):95–101.

    Article  CAS  PubMed  Google Scholar 

  13. Bai M, Qi X, Yang Z, Yin Z, Nie Y, Yuan S, Wu K, Han G, Fan D. Predictors of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt in cirrhotic patients: a systematic review. J Gastroenterol Hepatol. 2011;26(6):943–51.

    Article  PubMed  Google Scholar 

  14. Casadaban LC, Parvinian A, Minocha J, Lakhoo J, Grant CW, Ray Jr CE, Knuttinen MG, Bui JT, Gaba RC. Clearing the confusion over hepatic encephalopathy after tips creation: incidence, prognostic factors, and clinical outcomes. Dig Dis Sci. 2015;60(4):1059–66.

    Article  PubMed  Google Scholar 

  15. Rossi P, Salvatori FM, Fanelli F, Bezzi M, Rossi M, Marcelli G, Pepino D, Riggio O, Passariello R. Polytetrafluoroethylene-covered Nitinol Stent-Graft for transjugular intrahepatic portosystemic shunt creation: 3-year experience 1. Radiology. 2004;231(3):820–30.

    Article  PubMed  Google Scholar 

  16. Zivony AS, Chen L, Kaufman J, Zaman A. 992 the degree in reduction of portal-systemic gradient during tips and not final post-tips portal pressure gradient is predictive of the development of hepatic encephalopathy. Gastroenterology. 2014;146(5):S–932.

    Article  Google Scholar 

  17. Masson S, Mardini H, Rose J, Record C. Hepatic encephalopathy after transjugular intrahepatic portosystemic shunt insertion: a decade of experience. QJM. 2008;101(6):493–501.

    Article  CAS  PubMed  Google Scholar 

  18. Madoff DC, Wallace MJ, Ahrar K, Saxon RR. TIPS-related hepatic encephalopathy: management options with novel endovascular techniques. Radiographics. 2004;24(1):21–36 (discussion -7).

    Article  PubMed  Google Scholar 

  19. Kochar N, Tripathi D, Ireland H, Redhead DN, Hayes PC. Transjugular intrahepatic portosystemic stent shunt (TIPSS) modification in the management of post-TIPSS refractory hepatic encephalopathy. Gut. 2006;55(11):1617–23.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  20. Madoff DC, Wallace MJ. Reduced stents and stent-grafts for the management of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt creation. Semin Interv Radiol. 2005;22(4):316–28.

    Article  Google Scholar 

  21. Ripamonti R, Ferral H, Alonzo M, Patel NH. Transjugular intrahepatic portosystemic shunt-related complications and practical solutions. Semin Interv Radiol. 2006;23(2):165–76.

    Article  Google Scholar 

  22. Jalan R, Hayes PC. Risk of intentional reversible thrombosis of transjugular intrahepatic portosystemic shunt. Radiology. 1995;197(3):587.

    Article  CAS  PubMed  Google Scholar 

  23. Potts JR 3rd, Henderson JM, Millikan WJ Jr, Sones P, Warren WD. Restoration of portal venous perfusion and reversal of encephalopathy by balloon occlusion of portal systemic shunt. Gastroenterology. 1984;87(1):208–12.

    PubMed  Google Scholar 

  24. Pattynama PM, Wils A, van der Linden E, van Dijk LC. Embolization with the Amplatzer Vascular Plug in TIPS patients. Cardiovasc Interv Radiol. 2007;30(6):1218–21.

    Article  Google Scholar 

  25. Haskal ZJ, Middlebrook. Creation of a stenotic stent to reduce flow through a transjugular intrahepatic portosystemic shunt. J Vasc Interv Radiol. 1994;5(6):827–9 (discussion 9–30).

    Article  CAS  PubMed  Google Scholar 

  26. Forauer AR, McLean GK. Transjugular intrahepatic portosystemic shunt constraining stent for the treatment of refractory postprocedural encephalopathy: a simple design utilizing a Palmaz stent and Wallstent. J Vasc Interv Radiol. 1998;9(3):443–6.

    Article  CAS  PubMed  Google Scholar 

  27. Maleux G, Verslype C, Heye S, Wilms G, Marchal G, Nevens F. Endovascular shunt reduction in the management of transjugular portosystemic shunt-induced hepatic encephalopathy: preliminary experience with reduction stents and stent-grafts. Am J Roentgenol. 2007;188(3):659–64.

    Article  Google Scholar 

  28. Gerbes A, Waggershauser T, Holl J, Gülberg V, Fischer G, Reiser M. Experiences with novel techniques for reduction of stent flow in transjugular intrahepatic portosystemic shunts. Z Gastroenterol. 1998;36(5):373–7.

    CAS  PubMed  Google Scholar 

  29. Madoff DC, Perez-Young IV, Wallace MJ, Skolkin MD, Toombs BD. Management of TIPS-related refractory hepatic encephalopathy with reduced Wallgraft endoprostheses. J Vasc Interv Radiol. 2003;14(3):369–74.

    Article  PubMed  Google Scholar 

  30. Quaretti P, Michieletti E, Rossi S. Successful treatment of TIPS-induced hepatic failure with an hourglass stent-graft: a simple new technique for reducing shunt flow. J Vasc Interv Radiol. 2001;12(7):887–90.

    Article  CAS  PubMed  Google Scholar 

  31. Weintraub JL, Mobley DG, Weiss ME, Swanson E, Kothary N. A novel endovascular adjustable polytetrafluoroethylene-covered stent for the management of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt. J Vasc Interv Radiol. 2007;18(4):563–6.

    Article  PubMed  Google Scholar 

  32. Kroma G, Lopera J, Cura M, Suri R, El-Merhi F, Reading J. Transjugular intrahepatic portosystemic shunt flow reduction with adjustable polytetrafluoroethylene-covered balloon-expandable stents. J Vasc Interv Radiol. 2009;20(7):981–6.

    Article  PubMed  Google Scholar 

  33. Saket RR, Sze DY, Razavi MK, Kee STW, Frisoli JK, Semba CP, Dake MD. TIPS Reduction with use of stents or stent-grafts. J Vasc Interv Radiol. 2004;15(7):745–51.

    Article  PubMed  Google Scholar 

  34. Monnin-Bares V, Thony F, Sengel C, Bricault I, Leroy V, Ferretti G. Stent-graft narrowed with a lasso catheter: an adjustable tips reduction technique. J Vasc Interv Radiol. 2010;21(2):275–80.

    Article  PubMed  Google Scholar 

  35. Riggio O, Angeloni S, Salvatori FM, De Santis A, Cerini F, Farcomeni A, Attili AF, Merli M. Incidence, natural history, and risk factors of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt with polytetrafluoroethylene-covered stent grafts. Am J Gastroenterol. 2008;103(11):2738–46.

    Article  PubMed  Google Scholar 

  36. Kerlan RK Jr, LaBerge JM, Baker EL, Wack JP, Marx M, Somberg KA, Gordon RL, Ring EJ. Successful reversal of hepatic encephalopathy with intentional occlusion of transjugular intrahepatic portosystemic shunts. J Vasc Interv Radiol. 1995;6(6):917–21.

    Article  PubMed  Google Scholar 

  37. Cookson DT, Zaman Z, Gordon-Smith J, Ireland HM, Hayes PC. Management of transjugular intrahepatic portosystemic shunt (TIPS)-associated refractory hepatic encephalopathy by shunt reduction using the parallel technique: outcomes of a retrospective case series. Cardiovasc Interv Radiol. 2011;34(1):92–9.

    Article  Google Scholar 

  38. Shioyama Y, Matsueda K, Horihata K, Kimura M, Nishida N, Kishi K, Terada M, Sato M, Yamada R. Post-TIPS hepatic encephalopathy treated by occlusion balloon-assisted retrograde embolization of a coexisting spontaneous splenorenal shunt. Cardiovasc Inter Radiol. 1996;19(1):53–5.

    Article  CAS  Google Scholar 

  39. Pocha C, Maliakkal B. Spontaneous intrahepatic portal-systemic venous shunt in the adult: case report and review of the literature. Dig Dis Sci. 2004;49(7–8):1201–6.

    Article  PubMed  Google Scholar 

  40. Zardi EM, Uwechie V, Caccavo D, Pellegrino NM, Cacciapaglia F, Di Matteo F, Dobrina A, Laghi V, Afeltra A. Portosystemic shunts in a large cohort of patients with liver cirrhosis: detection rate and clinical relevance. J Gastroenterol. 2009;44(1):76–83.

    Article  PubMed  Google Scholar 

  41. Zidi SH, Zanditenas D, Gelu-Siméon M, Rangheard AS, Valla DC, Vilgrain V, Pelletier GM. Treatment of chronic portosystemic encephalopathy in cirrhotic patients by embolization of portosystemic shunts. Liver Int. 2007;27(10):1389–93.

    Article  PubMed  Google Scholar 

  42. Riggio O, Efrati C, Catalano C, Pediconi F, Mecarelli O, Accornero N, Nicolao F, Angeloni S, Masini A, Ridola L. High prevalence of spontaneous portal‐systemic shunts in persistent hepatic encephalopathy: a case‐control study. Hepatology. 2005;42(5):1158–65.

    Article  PubMed  Google Scholar 

  43. Qi X, Liu L, Bai M, Chen H, Wang J, Yang Z, Han G, Fan D. Transjugular intrahepatic portosystemic shunt in combination with or without variceal embolization for the prevention of variceal rebleeding: a meta-analysis. J Gastroenterol Hepatol. 2014;29(4):688–96.

    Article  PubMed  Google Scholar 

  44. Wu W, He C, Han G. Embolization of spontaneous splenorenal shunt for after-TIPS hepatic encephalopathy in a patient with cirrhosis and variceal bleeding. Hepatology. 2015;61(5):1761–2.

    Article  PubMed  Google Scholar 

  45. Uflacker R, Silva AO, d’Albuquerque L, Piske R, Mourao G. Chronic portosystemic encephalopathy: embolization of portosystemic shunts. Radiology. 1987;165(3):721–5.

    Article  CAS  PubMed  Google Scholar 

  46. Hanna SS, Smith RS III, Henderson JM, Millikan WJ Jr, Warren WD. Reversal of hepatic encephalopathy after occlusion of total portasystemic shunts. Am J Surg. 1981;142(2):285–9.

    Article  CAS  PubMed  Google Scholar 

  47. Kumamoto M, Toyonaga A, Inoue H, Miyakoda K, Morita Y, Emori K, Sakamoto Y, Oho K, Sata M. Long-term results of balloon-occluded retrograde transvenous obliteration for gastric fundal varices: Hepatic deterioration links to portosystemic shunt syndrome. J Gastroenterol Hepatol. 2010;25(6):1129–35.

    Article  PubMed  Google Scholar 

  48. An J, Kim K, Han S, Lee J, Lim YS. Improvement in survival associated with embolisation of spontaneous portosystemic shunt in patients with recurrent hepatic encephalopathy. Aliment Pharmacol Ther. 2014;39(12):1418–26.

    Article  CAS  PubMed  Google Scholar 

  49. Kimura K, Ohto M, Matsutani S, Furuse J, Hoshin K, Okuda K. Relative frequencies of portosystemic pathways and renal shunt formation through the “posterior” gastric vein: portographic study in 460 patients. Hepatology. 1990;12(4):725–8.

    Article  CAS  PubMed  Google Scholar 

  50. Saad WE, Sze DY. Variations of balloon-occluded retrograde transvenous obliteration (BRTO): Balloon-occluded antegrade transvenous obliteration (BATO) and alternative/adjunctive routes for BRTO. Seminars in interventional radiology. Newyork: Thieme Medical Publishers; 2011.

    Google Scholar 

  51. Saad WE, Kitanosono T, Koizumi J, Hirota S. The conventional balloon-occluded retrograde transvenous obliteration procedure: indications, contraindications, and technical applications. Tech Vasc Interv Radiol. 2013;16(2):101–51.

    Article  PubMed  Google Scholar 

  52. Uchiyama F, Murata S, Onozawa S, Nakazawa K, Sugihara F, Narahara Y, Amano Y, Kumita S. Management of gastric varices unsuccessfully treated by balloon-occluded retrograde transvenous obliteration: long-term follow-up and outcomes. Sci World J. 2013. doi:10.1155/2013/498535.

    Google Scholar 

  53. Arai H, Abe T, Takagi H, Mori M. Efficacy of balloon-occluded retrograde transvenous obliteration, percutaneous transhepatic obliteration and combined techniques for the management of gastric fundal varices. World J Gastroenterol. 2006;12(24):3866.

    PubMed Central  PubMed  Google Scholar 

  54. Tanaka O, Ishihara K, Oyamada H, Harusato A, Yamaguchi T, Ozawa M, Nakano K, Yamagami T, Nishimura T. Successful portal-systemic shunt occlusion with balloon-occluded retrograde transvenous obliteration for portosystemic encephalopathy without liver cirrhosis. J Vasc Interv Radiol. 2006;17(12):1951–5.

    Article  PubMed  Google Scholar 

  55. National Guideline C. ACR Appropriateness Criteria® radiologic management of gastric varices Rockville MD: Agency for Healthcare Research and Quality (AHRQ); [1/10/2015]. http://www.guideline.gov/content.aspx?id=37909.Accessed 10 Jan 2015.

  56. Saad WE, Wagner CC, Al-Osaimi A, Bliebel W, Lippert A, Davies MG, Sabri SS, Turba UC, Matsumoto AH, Angle JF. The effect of balloon-occluded transvenous obliteration of gastric varices and gastrorenal shunts on the hepatic synthetic function a comparison between child-pugh and model for end-stage liver disease scores. Vasc Endovasc Surg. 2013;47(4):281–7.

    Article  Google Scholar 

  57. Saad WE, Darcy MD. Transjugular intrahepatic portosystemic shunt (TIPS) versus balloon-occluded retrograde transvenous obliteration (BRTO) for the management of gastric varices. Seminars in interventional radiology. Newyork: Thieme Medical Publishers; 2011.

    Google Scholar 

  58. Scott J, Dick R, Long RG, Sherlock S. Percutaneous transhepatic obliteration of gastro-oesophageal varices. Lancet. 1976;2(7976):53–5.

    Article  CAS  PubMed  Google Scholar 

  59. Shi Y, Tian X, Hu J, Zhang J, Zhang C, Yang Y, Qin C. Efficacy of transjugular intrahepatic portosystemic shunt with adjunctive embolotherapy with cyanoacrylate for esophageal variceal bleeding. Dig Dis Sci. 2014;59(9):2325–32.

    Article  CAS  PubMed  Google Scholar 

  60. Xiao T, Chen L, Chen W, Xu B, Long Q, Li R, Li L, Peng Z, Fang D, Wang R. Comparison of transjugular intrahepatic portosystemic shunt (TIPS) alone versus TIPS combined with embolotherapy in advanced cirrhosis: a retrospective study. J Clin Gastroenterol. 2011;45(7):643–50.

    Article  PubMed  Google Scholar 

  61. Choi YS, Lee JH, Sinn DH, Song YB, Gwak G-Y, Choi MS, Koh KC, Paik SW, Yoo BC. Effect of balloon-occluded retrograde transvenous obliteration on the natural history of coexisting esophageal varices. J Clin Gastroenterol. 2008;42(9):974–9.

    Article  PubMed  Google Scholar 

  62. Park JK, Saab S, Kee ST, Busuttil RW, Kim HJ, Durazo F, Cho S-K, Lee EW. Balloon-occluded retrograde transvenous obliteration (BRTO) for treatment of gastric varices: review and meta-analysis. Dig Dis Sci. 2014:1–11.

  63. Tesdal IK, Filser T, Weiss C, Holm E, Dueber C, Jaschke W. Transjugular intrahepatic portosystemic shunts: adjunctive embolotherapy of gastroesophageal collateral vessels in the prevention of variceal rebleeding. Radiology. 2005;236(1):360–7.

    Article  PubMed  Google Scholar 

  64. Gaba RC, Bui JT, Cotler SJ, Kallwitz ER, Mengin OT, Martinez BK, Berkes JL, Carrillo TC, Knuttinen MG, Owens CA. Rebleeding rates following TIPS for variceal hemorrhage in the Viatorr era: TIPS alone versus TIPS with variceal embolization. Hep Intl. 2010;4(4):749–56.

    Article  Google Scholar 

  65. Smith M, Ray CE. Splenic artery embolization as an adjunctive procedure for portal hypertension. Seminars in interventional radiology. Newyork: Thieme Medical Publishers; 2011.

    Google Scholar 

  66. Hadduck TA, McWilliams JP. Partial splenic artery embolization in cirrhotic patients. World J Radiol. 2014;6(5):160–8.

    Article  PubMed Central  PubMed  Google Scholar 

  67. Yoshida H, Mamada Y, Taniai N, Yamamoto K, Kaneko M, Kawano Y, Mizuguchi Y, Kumazaki T, Tajiri T. Long-term results of partial splenic artery embolization as supplemental treatment for portal-systemic encephalopathy. Am J Gastroenterol. 2005;100(1):43–7.

    Article  PubMed  Google Scholar 

  68. Nüssler NC, Settmacher U, Haase R, Stange B, Heise M, Neuhaus P. Diagnosis and treatment of arterial steal syndromes in liver transplant recipients. Liver Transpl. 2003;9(6):596–602.

    Article  PubMed  Google Scholar 

  69. Quintini C, D’Amico G, Brown C, Aucejo F, Hashimoto K, Kelly DM, Eghtesad B, Sands M, Fung JJ, Miller CM. Splenic artery embolization for the treatment of refractory ascites after liver transplantation. Liver Transpl. 2011;17(6):668–73.

    Article  PubMed  Google Scholar 

  70. Zhu X, Tam MD, Pierce G, McLennan G, Sands MJ, Lieber MS, Wang W. Utility of the Amplatzer Vascular Plug in splenic artery embolization: a comparison study with conventional coil technique. Cardiovasc Interv Radiol. 2011;34(3):522–31.

    Article  Google Scholar 

  71. Guan YS, Hu Y. Clinical application of partial splenic embolization. T Sci World J. 2014. doi:10.1155/2014/961345.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Interventional Radiology, Jackson Memorial Hospital/University of Miami Hospital, Miami, FL, 33140, USA

    Keith Pereira, Jason Salsamendi, Mehul Doshi, Reginald Baker & Issam Kably

  2. Department of Hepatology, Jackson Memorial Hospital/University of Miami Hospital, Miami, FL, 33140, USA

    Andres F. Carrion

Authors
  1. Keith Pereira
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Andres F. Carrion
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jason Salsamendi
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Mehul Doshi
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Reginald Baker
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Issam Kably
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Keith Pereira.

Ethics declarations

Conflict of Interest

Keith Pereira, Andres F Carrion, Jason Salsamendi, Mehul Doshi, Reginald Baker, and Issam Kably declare that they have no conflict of interest.

Informed Consent

Consent was obtained from all individual participants included in this study.

Human and Animal Rights

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Pereira, K., Carrion, A.F., Salsamendi, J. et al. Endovascular Management of Refractory Hepatic Encephalopathy Complication of Transjugular Intrahepatic Portosystemic Shunt (TIPS): Comprehensive Review and Clinical Practice Algorithm. Cardiovasc Intervent Radiol 39, 170–182 (2016). https://doi.org/10.1007/s00270-015-1197-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00270-015-1197-x

Keywords

Search

Navigation